Coagulation Testing Market Growth Opportunities and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Coagulation Testing Market covers analysis By Product (Instruments Consumables); Application (Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), Prothrombin Time (PT)); Technology (Optical Technology, Mechanical Technology, Electrochemical Technology); End User (Hospitals, Clinical Laboratories, Point-Of-Care Testing), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00005211
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Coagulation Testing Market is expected to register a CAGR of 11.3% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.

The research report on the coagulation testing market is segmented by product type into instruments, consumables, and reagents. Applications analyzed include prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer testing, and others. End-users covered in the study are hospitals, diagnostic laboratories, and research institutes. The global market analysis is broken down by region and major countries, covering North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses.

Purpose of the Report

The report Coagulation Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Coagulation Testing Market Segmentation

Product

  • Instruments
  • Consumables

Application

  • Activated Clotting Time
  • Thrombin Time
  • Partial Thromboplastin Time
  • Activated Partial Thromboplastin Time
  • Prothrombin Time

Technology

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

End User

  • Hospitals
  • Clinical Laboratories
  • Point-Of-Care Testing

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Coagulation Testing Market: Strategic Insights

coagulation-testing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Coagulation Testing Market Growth Drivers

  • Rising Coagulation Disorders: The growing prevalence of coagulation disorders, including hemophilia, von Willebrand disease, and DVT, is one of the major factors propelling the market for coagulation testing. Hemophilia is a very rare genetic disorder that impairs the blood from clotting, resulting in recurring bleeding episodes. The World Federation of Hemophilia estimates that around 1 in 10,000 suffer from hemophilia worldwide. More significantly, DVTs, pulmonary embolisms, and strokes are very common today and have become increasing trends because the populations are becoming older, sated, and often suffer from obesity and diabetes conditions. As this incidence increases so does the increased need for testing coagulation tests among patients since more diagnostic tools, accurate and fast, are sought for healthcare providers when diagnosing this abnormality within the coagulation pathway.
  • Increased demand anticoagulants: Demand is being driven by the increasing use of anticoagulants, particularly in patients suffering from conditions such as atrial fibrillation, venous thromboembolism, and other cardiovascular diseases. Patients on anticoagulants, including warfarin, DOACs, and heparin, need regular monitoring of the efficacy of the drugs and potential adverse effects, such as excessive bleeding or clotting. This is driving the need for coagulation testing in the clinical arena. The American Heart Association informed that atrial fibrillation, typically treated with anticoagulants, impacts about 2.7 million to 6.1 million Americans. As demand for anticoagulants is on the rise, coagulation testing is expected to increase in market size as constant monitoring of blood clotting activity is required.
  • Technological Advancements in Coagulation Testing: Technologies of coagulation testing are other contributors to growing this market. Traditional methods of coagulation testing, such as prothrombin time (PT) and activated partial thromboplastin time (aPTT), are being supplemented or replaced by more advanced, faster, and more accurate technologies. The advent of point-of-care (POC) devices, which allow for near-instantaneous results, has significantly improved patient care by enabling quicker treatment decisions. Devices such as the CoaguChek® system for monitoring warfarin therapy are increasingly being used in outpatient settings because they provide real-time feedback and reduce the need for laboratory visits. Moreover, the development of next-generation coagulation analyzers with enhanced automation and multi-parametric testing capabilities is enabling healthcare providers to offer more comprehensive and precise diagnostics, thus fueling market growth.

Coagulation Testing Market Future Trends

  • Increasing adoption of Point-of-care testing: One of the most promising trends in the coagulation testing market is the increasing adoption of point-of-care testing. Immediate results from POC coagulation testing devices reduce the waiting time for patients and enhance swift clinical decision-making. These devices are especially helpful in emergency situations or for anticoagulant-treated patients where timely and precise results are crucial. POC devices are also increasingly being used in home healthcare as they enable patients to monitor their coagulation status and adjust their treatment accordingly. The trend of home healthcare and telemedicine is on the rise, and this is likely to further boost the growth of POC coagulation testing. There have been a reported number of observations related to patient improvement associated with point-of-care testing of improving the effectiveness in terms of providing quick readjustment to appropriate treatment regimes in conjunction with preventing any complications caused due to coagulation disorders.
  • Automation Trends: Recent Trend of Increasingly Automatization towards High Through-put Coagulation Testing Increased pressure toward improved efficiency, precision, and replication in a diagnostic laboratory. The increasing popularity of high-throughput coagulation analyzers-high throughput in large hospitals and diagnostic laboratories-is because these systems, while allowing for the simultaneous testing of a number of parameters, provide results in less time and thus improve workflow efficiency. Automation reduces the possibilities of human error and guarantees that each test will be carried out in consistency with reliable outcomes. It is critical especially because of the number of tests which tends to rise as well with more patients to monitor their coagulation, such as those found in high-activity hospitals. There has been increased investment in firms producing sophisticated, high-end coagulation testing devices, such as more automatic systems, that promise a much greater accuracy for diagnosis.
  • Integration of Coagulation Testing with Other Diagnostic Systems: Integration of Coagulation Testing with Other Diagnostic Systems provides another trend in the coagulation testing market. These integrations are mainly associated with hematology and clinical chemistry analyzers. Due to this integration, coagulation tests are conducted on multi-parameter diagnostic devices in healthcare settings, thereby streamlining the testing process and increasing overall diagnostic efficiency. This trend also supports the move toward more comprehensive and personalized healthcare, where multiple test results can be assessed together to provide a more complete picture of a patient's health. The integration of coagulation testing with other systems allows for better management of coexisting conditions like anemia, cardiovascular diseases, and kidney disorders, which often require the monitoring of coagulation parameters. The move towards integrated systems is likely to enhance the accuracy of diagnoses and the efficiency of healthcare services.

Coagulation Testing Market Opportunities

  • Personalized Coagulation Monitoring: The coagulation testing market also offers a future emerging opportunity in the form of personalized medicine. Tailoring coagulation treatments according to a patient's specific genetic makeup and health condition is the way healthcare is headed in the future. Genetic testing, for instance, may help predict the response of a patient to anticoagulant drugs, such as warfarin, so dosing can be appropriately adjusted. The integration of genetic markers into coagulation testing platforms is a promising avenue to improve the patient outcome and reduce adverse drug reactions. Personalized monitoring of coagulation is expected to be used more frequently as genetic testing becomes more accessible and more affordable. Such a trend will lead to improvements in managing diseases and avoidance of complications associated with coagulation disorders.
  • Coagulation Testing Applications: Applications of coagulation testing are not only limited to bleeding and clotting disorders but expanding in other health care areas. For example, coagulation tests are used increasingly in cancer care in monitoring the coagulation status of cancer patients who are at high risk of thromboembolic events. Coagulation tests are also indispensable in assessing the function of the liver since most clotting factors, involved in normal coagulation processes, are derived from the latter. The increasingly recognized role of coagulation tests in a variety of medical conditions and diseases opens broad markets for testing beyond traditional applications of coagulation testing. Consequently, manufacturers for coagulation testing products shall have huge prospects for growth with this development.
  • Portability and user friendliness: User friendlyness are expected of home coagulation tests. They tend to be provided as rapid-in-point-of-test results with only a minimal expertise level. Often used by coagulant therapeutic patients, namely warfarin patients, a portable INR is a sort of point-of-care testing devise meant for real time blood clot level monitoring. Patient medication can easily be adjusted during their therapy for blood clot correction.This home-based technique has been advantageous to the majority of the patient population, the elderly, especially those with problems in mobility and even to others living in a remote location. A study concluded by the National Center for Biotechnology Information determined that home-based coagulation testing may increase adherence, reduce costs to the care facility, and ultimately reduce health care costs for patients. Growing healthcare needs as systems evolve with a more focused approach toward improving patient outcomes through cost-effective medicine, the number of home coagulation monitoring devices will mushroom.

Coagulation Testing Market Regional Insights

The regional trends and factors influencing the Coagulation Testing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Coagulation Testing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

coagulation-testing-market-global-geography
  • Get the Regional Specific Data for Coagulation Testing Market

Coagulation Testing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 11.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Instruments
  • Consumables
By Application
  • Activated Clotting Time
  • Thrombin Time
  • Partial Thromboplastin Time
  • Activated Partial Thromboplastin Time
  • Prothrombin Time
By Technology
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
By End User
  • Hospitals
  • Clinical Laboratories
  • Point-Of-Care Testing
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • NIHON KOHDEN CORPORATION
  • Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Sysmex Corporation
  • Diagnostica Stago Sas
  • Coagulation Sciences LLC
  • Helena Laboratories
  • Medtronic
  • Micropoint Bioscience

  • Coagulation Testing Market Players Density: Understanding Its Impact on Business Dynamics

    The Coagulation Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Coagulation Testing Market are:

    1. Abbott
    2. NIHON KOHDEN CORPORATION
    3. Hoffmann-La Roche Ltd
    4. Thermo Fisher Scientific Inc
    5. Sysmex Corporation
    6. Diagnostica Stago Sas

    Disclaimer: The companies listed above are not ranked in any particular order.


    coagulation-testing-market-cagr

    • Get the Coagulation Testing Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Coagulation Testing Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Coagulation Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is the expected CAGR of the Coagulation Testing Market?

    The Coagulation Testing Market is expected to register a CAGR of 11.3% from 2025-2031.

    What are the driving factors impacting the Coagulation Testing Market?

    The major driving factors supporting the Coagulation Testing market growth are - The growing prevalence of coagulation disorders, increased use of anticoagulants, and technological advancements in coagulation testing

    What are the future trends in the Coagulation Testing Market?

    Key future trends in the Coagulation Testing Market are -

    Which are the key players in the Coagulation Testing Market?

    Key companies in the Coagulation Testing Market are- , Abbott, NIHON KOHDEN CORPORATION, Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Sysmex Corporation, Diagnostica Stago Sas, Coagulation Sciences LLC, Helena Laboratories, Medtronic, Micropoint Bioscience

    What are the deliverable formats of the Coagulation Testing Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies
    1. Abbott
    2. NIHON KOHDEN CORPORATION
    3. Hoffmann-La Roche Ltd
    4. Thermo Fisher Scientific Inc
    5. Sysmex Corporation
    6. Diagnostica Stago Sas
    7. Coagulation Sciences LLC
    8. Helena Laboratories
    9. Medtronic
    10. Micropoint Bioscience
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo